Fund profile · Compiled from public sources

EGB Capital Ventures

Pre-seed → Series A

Their stated focus (public profile)

EGB Ventures is a family office that creates and invests in clinical-stage pharmaceutical companies, focusing on oncology, infectious diseases, and central nervous system disorders. They identify breakthrough science, form new ventures around it, recruit executive teams, and provide hands-on strategic and operational guidance. Their emphasis is on areas of high unmet medical need, often rediscovering existing therapeutic assets with clinical history to reduce risk and accelerate patient access. Many portfolio companies are listed on the ASX.

Stages: Pre-seed → Series A

Sectors: Healthtech, Life sciences

Website: egbventures.com

This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.

Is this your fund? Request a correction or removal.

For founders · Find a fund

Search the funds we have on file

Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.

    Looking to claim your own fund? Start here →